| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 1971579 | Clinical Biochemistry | 2007 | 5 Pages |
Abstract
Our findings indicate that C5 gene variants and Gc-globulin levels co-define the proinflammatory and profibrogenic effects of C5 in patients at-risk for progression of liver fibrosis.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Olav Gressner, Ursula Meier, Sonja Hillebrandt, Hermann E. Wasmuth, Jörg Köhl, Tilman Sauerbruch, Frank Lammert,